Regeneron Pharmaceuticals, Inc. (REGN) vs Revolution Medicines, Inc. (RVMD)
- Regeneron Pharmaceuticals, Inc. REGN 790.74 −0.70%
- Revolution Medicines, Inc. RVMD 177.96 −5.97%
Regeneron Pharmaceuticals, Inc. and Revolution Medicines, Inc. are both Biotechnology companies. Regeneron Pharmaceuticals, Inc. is the larger, with a market value of $82.0B against $40.6B — 2.0× the size. Revolution Medicines, Inc. has negative trailing earnings, so its P/E is not meaningful; Regeneron Pharmaceuticals, Inc. trades at 18.9×. Regeneron Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 9.29% against −8.81%. Regeneron Pharmaceuticals, Inc. has the higher net margin (27.9% vs 0.00%) and the higher return on invested capital (9.34% vs 0.00%). Across the 19 metrics below, Regeneron Pharmaceuticals, Inc. leads on 18 and Revolution Medicines, Inc. on 1.
Valuation
Profitability
| Metric | REGN | RVMD | Biotechnology median |
|---|---|---|---|
| Gross margin | 84.86% | 35.06% | 65.16% |
| Operating margin | 24.74% | 0.00% | 0.00% |
| Net margin | 27.86% | 0.00% | 0.00% |
| Free cash flow margin | 23.01% | 0.00% | 0.00% |
| Return on equity | 14.04% | (79.09%) | (56.36%) |
| Return on assets | 10.83% | (52.37%) | (48.04%) |
| Return on invested capital | 9.34% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack